Overview Executive Committee Supervisory Board Locations
Overview Satraplatin Kinase Inhibitors
Stock Major Shareholdings Key Figures Financial Reports SEC Filings

Corporate Governance

Analyst Coverage Shareholder´s Meeting Webcasts Information Request
Press Releases Contact Information
Working for GPC Biotech Germany USA

More Info

Corporate Governance Declarations

Code of Conduct

Disclosure Committee

Management and Control Structures

Compensation of the Boards

Shareholdings of the Boards

Directors' Dealings

Print preview

Back

Print

Investor Relations


Coporate Governance | Disclosure Committee

In early 2006, GPC Biotech’s Management Board adopted a charter for a Disclosure Committee. The Committee is charged with assisting the Management Board in fulfilling its responsibility of overseeing the accuracy and timeliness of disclosures made by the Company. Responsibilities include designing, establishing and evaluating disclosure controls and procedures, as well as reviewing and supervising the preparation of various disclosure documents, such as filings with securities regulators and press releases containing information that is material to the Company’s investors. The Committee is also charged with implementing and reviewing a communications policy to govern interactions with the investment community and the media. The policy applies to all employees, as well as the Supervisory Board, the Management Board, and certain consultants. The Communications Policy was adopted by the Management Board in early 2006 and has been distributed to all affected parties.

Investor Relations | Corporate Governance